Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $120

Benzinga Newsdesk www.benzinga.com Positive 91.3%

Neg 0% Neu 0% Pos 91.3%

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and raises the price target from $105 to $120.